NCLT Directs Alkem Laboratories Shareholder Meeting for Adroit Biomed Merger

NCLT Mumbai Bench issues order on Alkem Laboratories' application to amalgamate its wholly-owned subsidiary Adroit Biomed Limited.
Tribunal directs Alkem to convene a meeting of its 65,140 equity shareholders to approve the scheme, dispensing with creditor meetings.
The appointed date for the amalgamation is fixed as 23 April 2025, aiming to consolidate dermatology and cosmetology business operations.
Order specifies detailed procedural requirements for shareholder notifications, publications, and appointments of Chairperson and Scrutiniser.